title: Effects of benzydamine eye drops on the rabbit's eye reaction to surgical, physical, and chemical stimuli.
abstract: The effects of benzydamine eye drops on the ocular reaction to different irritating stimuli in rabbits are reported. Benzydamine at the concentration of 0.1% reduces inflammatory tissue changes induced by AgNO3 burning of the cornea and inhibits the blood-aqueous barrier breakdown due to peripheral iridectomy or laser irradiation of the iris. Benzydamine reduces the aqueous PGE2 concentration to a similar extent as a 0.5% commercially available eye drop formulation of piroxicam. This result is in contrast with previous in vitro results demonstrating that benzydamine is devoid of any effects on PG synthesis. The possibility that PGE2 reduction is an indirect effect due to other biochemical activities of benzydamine is discussed. In the normal eye benzydamine manifests a local anaesthetic effect which is not accompanied by irritative changes in the anterior segment of the eye, changes in the intraocular pressure or pupillary size. It is suggested that in the clinical use of benzydamine eye drops the local anaesthetic activity may contribute to reducing both the neurogenic component of ocular inflammation and acute pain following injuries to the eye.
authors.affiliation: Institute of Ophthalmology, University of Verona, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Tomazzoli
authors.forename: A
authors.initials: A
authors.lastname: Bonora
authors.forename: M R
authors.initials: MR
authors.lastname: Luparini
authors.forename: L
authors.initials: L
authors.lastname: Durando
authors.forename: M G
authors.initials: MG
authors.lastname: Ciarniello
authors.forename: V
authors.initials: V
authors.lastname: Cioli
authors.forename: L
authors.initials: L
authors.lastname: Bonomi
mesh_terms: D000772:Anesthesia, Local; D000818:Animals; D001591:Benzydamine / Q000008:administration & dosage / Q000494:pharmacology*; D015232:Dinoprostone / Q000494:pharmacology; D005123:Eye / Q000187:drug effects; D005136:Eye Proteins / Q000378:metabolism; D005260:Female; D007498:Iris / Q000528:radiation effects / Q000601:surgery; D007509:Irritants; D007834:Lasers; D008297:Male; D009799:Ocular Physiological Phenomena; D009883:Ophthalmic Solutions; D013508:Ophthalmologic Surgical Procedures; D010812:Physical Stimulation; D010894:Piroxicam / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D011817:Rabbits; D012835:Silver Nitrate / Q000494:pharmacology; D013268:Stimulation, Chemical
chemical_list: D005136:Eye Proteins; D007509:Irritants; D009883:Ophthalmic Solutions; D011720:Pyrazoles; D010894:Piroxicam; D001591:Benzydamine; D012835:Silver Nitrate; D015232:Dinoprostone